These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1026 related items for PubMed ID: 18830124

  • 1. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
    Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ.
    Am J Surg Pathol; 2009 Jan; 33(1):111-9. PubMed ID: 18830124
    [Abstract] [Full Text] [Related]

  • 2. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [Abstract] [Full Text] [Related]

  • 3. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.
    Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Dec; 33(12):1878-85. PubMed ID: 19898224
    [Abstract] [Full Text] [Related]

  • 4. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
    Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J.
    J Clin Oncol; 2005 Jan 01; 23(1):127-32. PubMed ID: 15625367
    [Abstract] [Full Text] [Related]

  • 5. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
    Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ.
    Am J Surg Pathol; 2014 Jun 01; 38(6):729-42. PubMed ID: 24820399
    [Abstract] [Full Text] [Related]

  • 6. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.
    Am J Obstet Gynecol; 2006 Jun 01; 194(6):1702-9. PubMed ID: 16731090
    [Abstract] [Full Text] [Related]

  • 7. Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
    Reitsma W, de Bock GH, Oosterwijk JC, Bart J, Hollema H, Mourits MJ.
    Eur J Cancer; 2013 Jan 01; 49(1):132-41. PubMed ID: 22921157
    [Abstract] [Full Text] [Related]

  • 8. Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls.
    Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M.
    Gynecol Oncol; 2012 Oct 01; 127(1):88-93. PubMed ID: 22710074
    [Abstract] [Full Text] [Related]

  • 9. BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?
    Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY.
    Obstet Gynecol; 2005 Dec 01; 106(6):1327-34. PubMed ID: 16319259
    [Abstract] [Full Text] [Related]

  • 10. Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers.
    Carcangiu ML, Radice P, Manoukian S, Spatti G, Gobbo M, Pensotti V, Crucianelli R, Pasini B.
    Int J Gynecol Pathol; 2004 Jan 01; 23(1):35-40. PubMed ID: 14668548
    [Abstract] [Full Text] [Related]

  • 11. Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
    Cass I, Walts A, Karlan BY.
    Gynecol Oncol; 2010 Apr 01; 117(1):27-31. PubMed ID: 20110118
    [Abstract] [Full Text] [Related]

  • 12. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP.
    J Pathol; 2007 Jan 01; 211(1):26-35. PubMed ID: 17117391
    [Abstract] [Full Text] [Related]

  • 13. Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.
    George SH, Milea A, Shaw PA.
    Clin Cancer Res; 2012 Nov 15; 18(22):6199-207. PubMed ID: 22967960
    [Abstract] [Full Text] [Related]

  • 14. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U.
    BJOG; 2011 Jun 15; 118(7):814-24. PubMed ID: 21392246
    [Abstract] [Full Text] [Related]

  • 15. The fallopian tube-peritoneal junction: a potential site of carcinogenesis.
    Seidman JD, Yemelyanova A, Zaino RJ, Kurman RJ.
    Int J Gynecol Pathol; 2011 Jan 15; 30(1):4-11. PubMed ID: 21131840
    [Abstract] [Full Text] [Related]

  • 16. Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer.
    Lee Y, Medeiros F, Kindelberger D, Callahan MJ, Muto MG, Crum CP.
    Adv Anat Pathol; 2006 Jan 15; 13(1):1-7. PubMed ID: 16462151
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
    Staff S, Tolonen T, Laasanen SL, Mecklin JP, Isola J, Mäenpää J.
    Int J Gynecol Pathol; 2014 May 15; 33(3):309-16. PubMed ID: 24681744
    [Abstract] [Full Text] [Related]

  • 18. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K.
    N Engl J Med; 2002 May 23; 346(21):1609-15. PubMed ID: 12023992
    [Abstract] [Full Text] [Related]

  • 19. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
    Kauff ND, Barakat RR.
    J Clin Oncol; 2007 Jul 10; 25(20):2921-7. PubMed ID: 17617523
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
    Vicus D, Finch A, Rosen B, Fan I, Bradley L, Cass I, Sun P, Karlan B, McLaughlin J, Narod SA, Hereditary Ovarian Cancer Clinical Study Group.
    Gynecol Oncol; 2010 Aug 01; 118(2):155-9. PubMed ID: 20452659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.